SI
LONA

Sofinnova Investments’s LeonaBio Inc LONA Stock Holding History

Sofinnova Investments’s Portfolio LONA Stock Details LONA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-50,917
Closed -$9.37M – 68
2021
Q1 		$9.37M Hold
50,917
– – 0.56% 38
2020
Q4 		$17.4M Hold
50,917
– – 1.04% 22
2020
Q3 		$9.4M Buy
+50,917
New +$8.5M 0.7% 25

Other funds holding LONA

PA
Perceptive Advisors New York $6.66B AUM 360.84% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
RI
RTW Investments New York $11.7B AUM 174.13% 1-Year Est. Return
VA
VR Adviser New York $3.3B AUM 525.74% 1-Year Est. Return
LGM
Logos Global Management San Francisco, California $2.32B AUM 536.01% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
WA
Wasatch Advisors Salt Lake City, Utah $15.3B AUM 25.06% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return

Sofinnova Investments's LONA Position: Q2 2021 in Review

Sofinnova Investments sold out of LeonaBio Inc (LONA) in Q2 2021, closing a stake of 50,917 shares — an estimated $9.37M sold.

Sofinnova Investments first reported a position in LONA in Q3 2020 and held it in 3 quarters. The position peaked at $17.4M in Q4 2020. 88 funds tracked by Wall St. Rank hold LONA as of Q2 2021.

  • Sofinnova Investments reported no remaining LeonaBio Inc position as of Q2 2021 after selling out during the quarter.
  • Sofinnova Investments sold 50,917 LeonaBio Inc shares in Q2 2021, an estimated $9.37M.
  • Sofinnova Investments first reported a position in LeonaBio Inc in Q3 2020 and held it in 3 quarters.
  • Sofinnova Investments's LeonaBio Inc position peaked at $17.4M in Q4 2020.
  • 88 funds tracked by Wall St. Rank held LeonaBio Inc as of Q2 2021.

Based on Sofinnova Investments's 13F filing for Q2 2021, filed 16 Aug 2021.